The loss of DermTech under GAAP for the 3 months of 2022 was $30.108 million, doubling from $15.068 million in the previous year. Revenue increased 47.3% to $3.718 billion compared to $2.524 billion a year earlier.
The loss of DermTech under GAAP for the 3 months of 2022 was $30.108 million, doubling from $15.068 million in the previous year. Revenue increased 47.3% to $3.718 billion compared to $2.524 billion a year earlier. 
investors.dermtech.com
English (US) 